Moore Capital Management’s Immunomedics Inc IMMU Stock Holding History

Moore Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-120,000	Closed	-$10.2M	–	670
2020 Q3	$10.2M	Buy	+120,000	New	+$6.07M	0.19%	108
2019 Q2	–	Sell	-366,793	Closed	-$7.05M	–	410
2019 Q1	$7.05M	Buy	366,793 +237,752	+184%	+$3.83M	0.22%	118
2018 Q4	$1.84M	Buy	+129,041	New	+$2.56M	0.07%	156

Moore Capital Management's IMMU Position: Q4 2020 in Review

Moore Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 120,000 shares — an estimated $10.2M sold.

Moore Capital Management first reported a position in IMMU in Q4 2018 and held it in 3 quarters. The position peaked at $10.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Moore Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Moore Capital Management sold 120,000 Immunomedics Inc shares in Q4 2020, an estimated $10.2M.
Moore Capital Management first reported a position in Immunomedics Inc in Q4 2018 and held it in 3 quarters.
Moore Capital Management's Immunomedics Inc position peaked at $10.2M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Moore Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.